Skip to content

SILO PHARMA, INC.: 10-Q filed 2023-08-11

What SILO PHARMA, INC. reported in its quarterly report filed 2023-08-11 (fiscal Q2 2023): 33 published measures, 97 facts as tagged in accession 0001213900-23-066300.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-11
Fiscal period
fiscal Q2 2023
Accession
0001213900-23-066300 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SILO PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-3010,245,587USD
At 2022-12-3111,642,877USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-301,949,923USD
At 2022-12-311,302,100USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-308,295,664USD
At 2023-03-319,443,857USD
At 2022-12-3110,340,777USD
At 2022-06-307,874,037USD
At 2022-03-318,503,203USD
At 2021-12-319,062,266USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-06-30158,832USD
At 2022-12-3111,367,034USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1,012,951USD91
2023-01-01 to 2023-06-30-1,919,347USD181
2023-01-01 to 2023-03-31-906,396USD90
2022-04-01 to 2022-06-30-658,402USD91
2022-01-01 to 2022-06-30-1,262,474USD181
2022-01-01 to 2022-03-31-604,072USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-1,242,654USD181
2022-01-01 to 2022-06-30-1,189,274USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-04-01 to 2023-06-3018,025USD91
2023-01-01 to 2023-06-3036,051USD181
2022-04-01 to 2022-06-3018,025USD91
2022-01-01 to 2022-06-3036,051USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-130,959USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-9,834,589USD181
2022-01-01 to 2022-06-3086,707USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-9,090,475USD
At 2022-12-31-7,171,128USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-303,153,852shares91
2023-01-01 to 2023-06-303,156,311shares181
2022-04-01 to 2022-06-301,987,906shares91
2022-01-01 to 2022-06-301,980,365shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-04-01 to 2023-06-303,153,852shares91
2023-01-01 to 2023-06-303,156,311shares181
2022-04-01 to 2022-06-301,987,906shares91
2022-01-01 to 2022-06-301,980,365shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-04-01 to 2023-06-30169,186USD91
2023-01-01 to 2023-06-30331,443USD181
2022-04-01 to 2022-06-30100,212USD91
2022-01-01 to 2022-06-30227,393USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1,114,985USD91
2023-01-01 to 2023-06-30-1,918,470USD181
2022-04-01 to 2022-06-30-494,285USD91
2022-01-01 to 2022-06-30-1,021,544USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-3010,177,685USD
At 2022-12-3111,572,056USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,863USD91
2023-01-01 to 2023-06-303,518USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-301,120,192USD
At 2022-12-31436,318USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,131,551USD91
2023-01-01 to 2023-06-301,951,602USD181
2022-04-01 to 2022-06-30510,851USD91
2022-01-01 to 2022-06-301,054,676USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-3016,566USD91
2023-01-01 to 2023-06-3033,132USD181
2022-04-01 to 2022-06-3016,566USD91
2022-01-01 to 2022-06-3033,132USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,459USD91
2023-01-01 to 2023-06-302,919USD181
2022-04-01 to 2022-06-301,459USD91
2022-01-01 to 2022-06-302,919USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-04-01 to 2023-06-30239,100USD91
2023-01-01 to 2023-06-30304,066USD181
2022-04-01 to 2022-06-3025,918USD91
2022-01-01 to 2022-06-3062,743USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-04-01 to 2023-06-30130,719USD91
2023-01-01 to 2023-06-30333,632USD181
2022-04-01 to 2022-06-30105,676USD91
2022-01-01 to 2022-06-30275,955USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-303,108,797shares
At 2022-12-313,158,797shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-06-30158,832USD
At 2022-12-3111,367,034USD
At 2022-06-308,734,434USD
At 2021-12-319,837,001USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-3017,405,310USD
At 2022-12-3117,511,589USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-06-30-3,281USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-12-3120,134USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-06-30121,334USD
At 2022-12-31135,894USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1,012,951USD91
2023-01-01 to 2023-06-30-1,919,347USD181
2022-04-01 to 2022-06-30-658,402USD91
2022-01-01 to 2022-06-30-1,261,311USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1,021,471USD91
2023-01-01 to 2023-06-30-1,922,628USD181
2022-04-01 to 2022-06-30-658,402USD91
2022-01-01 to 2022-06-30-1,262,474USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-04-01 to 2023-06-30102,034USD91
2023-01-01 to 2023-06-30-877USD181
2022-04-01 to 2022-06-30-164,117USD91
2022-01-01 to 2022-06-30-239,767USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-06-303,518USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-06-3025,159USD181

Inspect the source

Entity
SILO PHARMA, INC. / CIK 0001514183
Captured
2026-09-20T09:13:20.337Z
SEC response SHA-256
b55b01ff5b31c52a933a54029f5fe837eae02333bd43de16acad37f51e3b67db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001514183.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))